Sun, Apr 20, 2014, 1:12 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • trangy trangy Nov 12, 2013 11:15 AM Flag

    Overreacting

    People are overreacting for a while but they're not stupid. They won't sell for a big loss forever. When they stop selling, stock will recover.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • trump3000@gmail.com trump3000 Nov 12, 2013 11:17 AM Flag

      THis will squeeze higher in a bit

      • 1 Reply to trump3000
      • This isn't going to squeeze anywhere. If you read what the FDA actually said about the application, you will see that drug is not going to get approval. When you invest in bio, you need to take your loss and move on. There are plenty of bio tech companies with incredible potential and multiple drugs in the pipeline that already show promise: for instance, CLDX. When investing in such companies, it is wise to look at how the successful ones grew: VRUS, AEGR, etc. SRPT does not have the characteristics those companies had, while CLDX does. I'm not in SRPT, but I have had my share of disasters. It is high risk high reward investing and there is nothing worse than turning a disaster into a long term dead money hold. Praying and hoping doesn't help. SRPT will be below 10 in the coming weeks and it won't recover anytime soon, if ever.

 
SRPT
24.40+0.17(+0.70%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.